Abstract: Four new briarane diterpenoids, junceellolides M-P (1-4), were isolated together with seven known analogs (5-11) from the South China Sea gorgonian, Junceella gemmacea. The structures of these compounds were elucidated by detailed spectroscopic analysis and comparison with the reported data. The absolute configuration of compounds 1-3 were determined based on an ECD experiment, while the absolute configuration of compound 4 was genetically determined. All the compounds were isolated for the first time from J. gemmacea. These compounds showed no growth inhibitory activity against A549, MG63 and SMMC-7721 cell lines in an in vitro bioassay.
Introduction
Gorgonian corals of the genus Junceella (phylum, Cnidaria; class, Anthozoa; order, Gorgonacea; family, Ellisellidae) are widely distributed in the subtropical and tropical waters of the Indo-Pacific Ocean as whip-shaped unbranched colonies of variable colors. These animals are well-known as a source of highly oxidized diterpenes of the briarane class [1, 2] . Briarane-related natural products are characterized by the presence of a γ-lactone fused to a bicyclo [8.4 .0] ring system [3] and have attracted great attention due to their chemical diversity and wide spectrum of bioactivities, including cytotoxic [4] , anti-inflammatory [5] , antibacterial [6] , immunomodulatory [7] , anti-fouling [8] and insecticidal [9] effects. Chemical investigation on the genus of Junceella can be traced back to 1983, at which time the isolation of junceellin [10] was reported from the Chinese gorgonian Junceella squamata [1] . Since then, more than 140 briarane diterpenes have been isolated from members of this genus, which involves four species, namely J. juncea, J. fragilis, J. gemmacea and J. squamata [1, 11] . Previous research activities have been focused on J. juncea and J. fragilis, and only a few reports have dealt with corals belonging to the species J. gemmacea and J. squamata [2] .
In our ongoing search for novel and bioactive secondary metabolites from marine invertebrates of the South China Sea, we were attracted by the potential medicinal value of the briarane diterpenoids. Previously, we reported the isolation of a series of briarane-type diterpenes with antimicrobial and tumor cell growth inhibition activities from the gorgonian, Dichotella gemmacea [12] [13] [14] [15] . These results inspired us to continue to examine this class of metabolites, leading to the present investigation of the gorgonian J. gemmacea which was previously reported to be a rich source of briarane diterpenes. Chemical investigation on the acetone extract of these animals resulted in the isolation of four new briarane diterpenes, junceellolides M-P (1-4), together with seven known ones, namely junceellolide A (5), junceellin A (6), praelolide (7), juncin ZI (8), junceellolide B (9), junceellolide C (10) and junceellolide D (11) (Figure 1 ). The structures of these compounds were elucidated by extensive spectroscopic analysis (  1 H and  13 C NMR, DEPT, HSQC, HMBC, NOESY,  1 H-1 H COSY and HRESIMS) and comparison with the reported analytical data for the known compounds. We herein report the isolation, structural determination and bioactivities of these new compounds.
Results and Discussion
Colonies of the gorgonian coral J. gemmacea (Valenciennes) were immediately frozen after collection and stored at −20 °C until extraction. The frozen organism was cut into small pieces and extracted exhaustively with acetone and methanol at room temperature. The Et 2 O-soluble portion (13.0 g) of the acetone extract was chromatographed repeatedly over silica gel, Sephadex LH-20, and semi-preparative RP-HPLC, to afford compounds 1-11. By extensive spectroscopic analysis combined with careful comparison with the reported data, the structures of the known compounds were determined as junceellolide A (5) [16] , junceellin A (6) [1, 10] , praelolide (7) [16] , juncin ZI (8) [17] , junceellolide B (9) [16] , junceellolide C (10) [16] and junceellolide D (11) [16] . Junceellin A (6) and juncin ZI (8) were once reported from J. squamata and J. juncea, respectively, and their structures were elucidated on the basis of ESIMS, UV, IR and NMR techniques. The structures of junceellolides A-D (5, 9-11) and praelolide (7), previously obtained from the South China Sea gorgonian, J. fragilis, were also established by extensive spectroscopic analysis. NMR shifts for C-11 and C-20 are at δ 62-63 and 58-60 when the epoxy group is β-oriented and at δ 55-61 and 47-52 ppm when α-oriented [19] . The relative configuration of 1 was thus determined as (1R*,2S*,3Z,5E,7S*,8S*,9S*,10S*,11R*,14S*,17R*). Because compound 1 contained the same lactone and diene chromophores as gemmacolide N (13) [14] , and because they differed only in the nature of the ester group at the C-12 and C-16 positions, the ECD spectrum of gemmacolide N could be used as an ECD reference for the configurational assignment of junceellolide M. Based on a negative ECD transition in the region 250-200 nm and a positive band below 200 nm, the absolute configuration of 1 was determined as (-)-(1R,2S,3Z,5E,7S,8S,9S,10S, Junceellolide N (2) was obtained as a white powder. The molecular formula was determined to be C 26 The connections of these proton sequences led to the establishment of the planar structure of 4 by the observation of distinct HMBC correlations from H 3 -15 to C-1, C-2, C-10 and C-14, H 2 -16 to C-4 and C-5, H-6 to C-16, H-17 to C-7, C-8, C-9 and C-19, H-9 to C-8 and H 2 -20 to C-10, C-11 and C-12, respectively ( Figure 5 ). The relative configurations at chiral centers were proven to be the same as those of compounds 1-3. Interestingly, the large coupling constant for the olefinic protons (J = 16.8 Hz) indicated an E geometry of Δ 3 in 4 in contrast to those of the Z double bonds in structures 1-3. To our knowledge, this is the first report of a trans Δ 3, 5 conjugated diene in a briarane diterpenoid. The relative configuration of 4 was established by NOE ( Figure 6 ) and coupling constant analysis whereas we propose its absolute configuration as (1R,2S,3E,5E,7S,8S,9S,10S,11R,14S,17R)-4, due to its biogenetic correlation with those of compounds 1-3. Compounds 1-11 were evaluated for their ability to inhibit tumor cell growth using the A549, MG63 and SMMC-7721 cell lines [20] . None of these compounds exhibited growth inhibitory effects against these cell lines in the in vitro bioscreening (IC 50 ≥ 40 µM). 
Experimental Section

General Experimental Procedures
Commercial silica gel (Yantai, China, 200-300; 400-500 mesh) and RP silica gel (Merck, Darmstadt, Germany, 43-60 µm) were used for column chromatography (CC). Sephadex LH-20 (GE Healthcare Bio-Sciences AB, SE-751 84 Uppsala, Sweden) was used for either purification or separation. TLC was carried out on precoated silica gel plates (Yantai, China, HSGF-254) and RP silica gel (Macherey-Nagel, Düren, Germany, RP-18 F254), and spots were detected on TLC under UV and visualized by spraying with anisaldehyde-sulfuric acid reagent, followed by heating. HPLC was performed using a system comprised of an Agilent G1311A pump, an Agilent G1315B DAD detector and a Rheodyne 7725 injection port. A semi-preparative normal-phase column (YMC Pack ODS-A, 250  10 mm I.D., particle size 5 µm, 250 × 10 mm, YMC Europe GmbH, Dinslaken, Germany) was used for HPLC. The NMR data were recorded on a Bruker DRX 400 and Avance 500 spectrometers at 400 or 500 MHz for 1 on a Varian Cary 100 UV-Vis spectrophotometer; peak wavelengths are reported in nanometers. Circular dichroism spectra were recorded with a JASCO J-715 circular dichroism spectropolarimeter. The HRMS were performed on a Q-TOF micro-mass spectrometer (resolution: 5000). An isopropyl alcohol solution of sodium iodide (2 mg/mL) was used as a reference compound.
Animal Material
Specimens of the gorgonian coral Junceella gemmacea were collected from the South China Sea in October 2011, and identified by Xiu-Bao Li of the South China Sea Institute of Oceanology, Academia Sinica. The voucher specimen was deposited in the Second Military Medical University, Shanghai, China.
Extraction and Isolation
The frozn animals (2500 g, wet weight) were cut into small pieces and extracted ultrasonically for four times (3000 mL × 4) with acetone and MeOH at room temperature. The organic extracts were concentrated under vacuum to give a residue, which was suspended into H 2 O and extracted with diethyl ether and n-butanol for four times, respectively. The Et 2 O-soluble portion was separated on a Sephadex LH-20 column (CH 2 Cl 2 :MeOH 1:1) giving fractions 1-10 (Fr.1~Fr.10). Fr.6 was subjected to SiO 2 column chromatography using solvents of increasing polarity from petroleum to acetone (TLC (GF 254) monitoring) to obtain eleven subfractions (P.1~P.11). P.11 was separated by reversed-phase silica gel chromatography (gradient MeOH/H 2 O, from 30:70 to 0:100), followed by semi-preparative RP-HPLC (MeOH/H 2 O, 58:42, flow rate of 2.0 mL/min), to yield compounds 1 (4.2 mg, t R 35 min) and 3 (3.7 mg, t R 32 min). Fr.8 was fractioned on silica gel eluting with petroleum/acetone (stepwise, 20:1-0:1) and then chromatographed on a gravity column with ODS using MeOH/water (gradient from 30:70 to 0:100, in 10% increments) as the eluent to afford subfractions S.10 and S.11. S.10 was isolated by reversed-phase silica gel chromatography (gradient elution from MeOH/H 2 O (30:70) to 100% MeOH, in 10% increments) and successively subjected to RP-HPLC (MeOH/H 2 O 79:21, 2 mL/min), producing 5 (2.6 mg, t R 29 min). S.11 was chromatographed over RP-silica gel column chromatography using a gradient of MeOH/H 2 O (30:70 to 0:100, in 10% increments) to yield subfractions R.4 and R.5. A HPLC chromatographic isolation on R.4 (MeOH/H 2 O 62:38, 2 mL/min) led to the preparation of 2 (2.4 mg, t R 60 min), 8 (2.3 mg, t R 39 min), 10 (4.9 mg, t R 53 min) and 11 (3.4 mg, t R 83 min). Furthermore, R.5 was further separated by HPLC using MeOH/H 2 O (56:44) at the flow rate of 2.0 mL/min and provided 4 (5.9 mg, t R 51 min) and 9 (1.6 mg, t R 54 min). Using petroleum/acetone (7:1) 
Cytotoxicity Assay
Compounds 1-11 were evaluated for cytotoxicity against human lung adenocarcinoma (A549), human osteosarcoma cell (MG63) and human hepatocellular carcinoma cell lines (SMMC-7721), using a modification of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric method [21] . Adriamycin was used as a positive control.
Conclusions
Chemical investigation of the South China Sea gorgonian, Junceella gemmacea (Valenciennes), has led to the isolation of four new 3,5-dien-7,18-olide briarane-type diterpenoids, junceellolides M-P (1-4), along with seven previously described analogues (5) (6) (7) (8) (9) (10) (11) . All the compounds were reported for the first time from Junceella gemmacea. The compounds were tested for growth inhibition activity against A549, MG63 and SMMC-7721 cell lines but were found to be inactive.
The isolation of an array of briarane diterpenoids demonstrates the productive chemical diversity of the gorgonian coral J. gemmacea, similar to that found in other species of this genus as well as in the genus Dichotella [2, 20, 22] The complexity of these intriguing structures and variable potential for tumor cell growth inhibition activity of compounds in this structure class may attract additional attention from chemists and pharmacologists, and encourage further investigations on the chemistry and antitumor activity of this cluster of metabolites.
